Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect
: \amt\Interwoven\NRPortbl\DCC\AMT\16374362_l.docx-30/01/2018 Disclosed in the present invention are antibodies against hepatitis B core protein (Anti-HBc) quantitative detection method and the uses thereof in monitoring and controlling disease progression of a chronic hepatitis B patient and in pre...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | : \amt\Interwoven\NRPortbl\DCC\AMT\16374362_l.docx-30/01/2018 Disclosed in the present invention are antibodies against hepatitis B core protein (Anti-HBc) quantitative detection method and the uses thereof in monitoring and controlling disease progression of a chronic hepatitis B patient and in predicting therapeutic effect. Anti-HBc are quantitatively detected, so that disease progression of a chronic hepatitis B patient is monitored and controlled, and the therapeutic effect on a chronic hepatitis B patient under anti-hepatitis B virus (HBV) treatment (especially, under treatment based on interferon and under treatment through anti-HBV medicine based on nucleoside or nucleotide analogues) is effectively predicted, thereby guiding the patient to reasonably select medicine. |
---|